Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis

American Heart Journal

Volumn 131, Issue 4, 1996, Pages 663-667

  Bui, Minh N ^a   Sack, Michael N ^a   Moutsatsos, George ^a   Lu, David Y ^b   Katz, Paul ^a   McCown, Rosemary ^a   Breall, Jeffery A ^a   Rackley, Charles E ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SMOKING;

EID: 0029929276     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90268-9     Document Type: Article

References (30)

1. Steinberg D, Witztum JL. Lipoproteine and atherogenesis. JAMA 1990;264:3047-52.
2. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A 1984;81:3883-7.
3. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low-density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1987;74:1890-4.
4. Steinberg D, Parthasarathy S, Carew TE, Khoo JD, Witztum JL. Beyond cholesterol: modification of low density lipoprotein that increases its atherogenicity. N Engl J Med 1989;320:915-24.
5. Palinski W, Ylä-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990;10:325-35.
6. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parathasarathy S, Butler TE, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-95.
7. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler BW, Parthasarathy S, CarewTE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 1989;86:1372-6.
8. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7.
9. Puurunen M, Manttari M, Manninen V, Tenkanen L, Alfthan G, Ehnholm C, Vaarala O, Aho K, Palosuo T. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med 1994;154:2605-9.
10. Holvoet P, Perez G, Zhao Z, Brouwers E, Bernar H, Collen D. Malon-dialdehyde-modified LDL in patients with atherosclerotic disease. J Clin Invest 1995;95:2611-9.
11. Sack MN, Rader DJ, Cannon RO III. Oestrogen and inhibition of oxidation of low-density lipoproteine in postmenopausal women. Lancet 1994;343:269-70.
12. Craig WY, Poulin SE, Nelson CP, Ritchie RF. ELISA of IgG antibody to oxidized LDL: effects of blocking buffer and method of data expression. Clin Chem 1994;40:882-8.
13. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-92.
14. Maggi E, Chisa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Pellomo G. LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arterioscler Thrombo 1994;14:1892-9.
15. Romm PA, Green CE, Reagan K, Rackley CE. Relationship of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. Am J Cardiol 1991;67:479-83.
16. Mao SJT, Yates MT, Parker RA, Chi EM, Jackson RL. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Wantanabe rabbits with use of a probucol analogue (MDL 29, 311) that does not lower serum cholesterol. Arterioscler Thrombo 1991;11:1266-75.
17. Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993; 94:350-6.
18. Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL. Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet 1994;343:645-6.
19. Armstromg VW, Wieland C, Deidrich F, Renner A, Rath W, Kreuger H, Kuhn W, Oellerich M. Serum antibodies to oxidized low-density lipoprotein in pre-eclampsia and coronary heart disease. Lancet 1994; 343:1570.
20. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Timo Palosuo. Cross reaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythomatosus. Lancet 1993;341:923-5.
21. Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989;79:287-91.
22. Kuhn FE, Mohler ER, Satler CE, Reagan K, Lu DY, Rackley CE. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. Am J Cardiol 1991;68:1425-30.
23. Nissen SE, Gurley JC, Grines CL, Booth DC, Fischer C, DeMaria AN. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991;84:1087-99.
24. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994;23:833-43.
25. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into the prevention of plaque disruption and clinical events in coronary disease. Circulation 1993;87:1781-91.
26. Brown BG, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan CK, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-98.
27. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-34.
28. Vita JA, Treature CB, Nabel EA. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-7.
29. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ, Ganz P, Selwyn AP. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991;325:1551-6.
30. Zeigher AM, Drexler H, Wollschlager H, Jurt H. Modulation of coronary vascular tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83:391-401.